Clinical pharmacology of gold
- PMID: 18523733
- DOI: 10.1007/s10787-007-0021-x
Clinical pharmacology of gold
Abstract
Since the dawn of civilization, elemental gold and gold compounds have been revered and utilized by Shamen and medical practitioners alike for many varied pathological problems. In the 20(th) century following the observations of Jacques Forestier, injectable gold compounds were successfully used for the treatment of rheumatoid arthritis. Of the many compounds developed, gold sodium thiomalate has been the most extensively studied by basic scientists and by clinicians. In the1980s, the oral gold compound auranofin showed promise as a therapeutic contender to injectable gold, but the clinical side effect profile and fear of long term effects of immune suppression by auranofin, resulted in gold sodium thiomalate continuing as the preferred gold compound for rheumatoid treatment. However, the increased use and demonstration of effectiveness of low dose Methotrexate (MTX) in rheumatoid treatment over the last 20 years has resulted in a significant decline in the use of injectable gold sodium thiomalate, this despite the claims and evidence that it remains a useful agent in the management of rheumatoid arthritis. Several authors still contend that the injectable gold compounds can still play a valuable role, and indeed may be the correct first choice in the management of rheumatoid arthritis.
Similar articles
-
Pharmacology of auranofin: overview and update.Scand J Rheumatol Suppl. 1986;63:19-28. Scand J Rheumatol Suppl. 1986. PMID: 3110942 Review.
-
Auranofin.Clin Rheum Dis. 1984 Aug;10(2):369-83. Clin Rheum Dis. 1984. PMID: 6239742 Review.
-
[The pharmacology of gold compounds].Wien Klin Wochenschr Suppl. 1984;156:7-13. Wien Klin Wochenschr Suppl. 1984. PMID: 6442062 Review. German.
-
Review of auranofin, an oral chrysotherapeutic agent.Clin Pharm. 1984 Mar-Apr;3(2):121-7. Clin Pharm. 1984. PMID: 6426843 Review.
-
Gold therapy. II. Historical, chemical, pharmacological and biological profile of anti-arthritic gold compounds.Singapore Med J. 1987 Apr;28(2):117-25. Singapore Med J. 1987. PMID: 3155422 No abstract available.
Cited by
-
Efficacy of auranofin as an inhibitor of desmoid progression.Sci Rep. 2022 Jul 13;12(1):11918. doi: 10.1038/s41598-022-15756-9. Sci Rep. 2022. PMID: 35831372 Free PMC article.
-
A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.Amino Acids. 2012 Feb;42(2-3):803-11. doi: 10.1007/s00726-011-0997-9. Epub 2011 Aug 11. Amino Acids. 2012. PMID: 21833767 Free PMC article.
-
A novel multimodal nanoplatform for targeting tumor necrosis.RSC Adv. 2021 Sep 15;11(47):29486-29497. doi: 10.1039/d1ra05658a. eCollection 2021 Sep 1. RSC Adv. 2021. PMID: 35479549 Free PMC article.
-
Q-Switched Alexandrite Laser-induced Chrysiasis.J Clin Aesthet Dermatol. 2015 Sep;8(9):48-53. J Clin Aesthet Dermatol. 2015. PMID: 26430491 Free PMC article.
-
To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology.Inflammopharmacology. 2017 Apr;25(2):185-190. doi: 10.1007/s10787-017-0320-9. Epub 2017 Feb 13. Inflammopharmacology. 2017. PMID: 28194545 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
